Pallas Capital Advisors’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $303K | Sell |
1,174
-1,924
| -62% | -$496K | 0.01% | 648 |
|
2025
Q1 | $693K | Buy |
3,098
+330
| +12% | +$73.9K | 0.03% | 382 |
|
2024
Q4 | $633K | Buy |
2,768
+751
| +37% | +$172K | 0.03% | 319 |
|
2024
Q3 | $482K | Buy |
2,017
+724
| +56% | +$173K | 0.02% | 366 |
|
2024
Q2 | $264K | Buy |
+1,293
| New | +$264K | 0.01% | 434 |
|
2023
Q2 | – | Sell |
-1,180
| Closed | -$271K | – | 294 |
|
2023
Q1 | $271K | Buy |
1,180
+7
| +0.6% | +$1.61K | 0.03% | 229 |
|
2022
Q4 | $275K | Sell |
1,173
-90
| -7% | -$21.1K | 0.03% | 231 |
|
2022
Q3 | $264K | Sell |
1,263
-28
| -2% | -$5.85K | 0.03% | 216 |
|
2022
Q2 | $299K | Hold |
1,291
| – | – | 0.04% | 187 |
|
2022
Q1 | $302K | Sell |
1,291
-64
| -5% | -$15K | 0.04% | 200 |
|
2021
Q4 | $319K | Sell |
1,355
-15
| -1% | -$3.53K | 0.04% | 245 |
|
2021
Q3 | $367K | Buy |
1,370
+89
| +7% | +$23.8K | 0.04% | 276 |
|
2021
Q2 | $350K | Buy |
1,281
+85
| +7% | +$23.2K | 0.05% | 234 |
|
2021
Q1 | $231K | Buy |
+1,196
| New | +$231K | 0.05% | 167 |
|